Study record managers: refer to the Data Element Definitions if submitting registration or results information.
|1||NCT01691898||Active, not recruiting
|A Study of Pinatuzumab Vedotin (DCDT2980S) Combined With Rituximab or Polatuzumab Vedotin (DCDS4501A) Combined With Rituximab or Obinutuzumab in Participants With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)||
||230||All||18 Years and older (Adult, Older Adult)||NCT01691898||GO27834
|ROMULUS||September 27, 2012||March 8, 2017||February 12, 2019||September 25, 2012||April 19, 2018||April 19, 2018||